XYNOS KONSTANTINOS (Chief Medical Officer) received a stock award from REPLIMUNE GROUP, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/8/2026ACC: 0001104659-26-040575
Officer· Chief Medical Officer
Since Dec 2022
+125K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
125K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
25.0%
4/1/2026
199.69K→249.69K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | A · Award | +50K | — | — | 25.0% | 199.69K | 249.69K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
7.61
Held after
75K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock75K shares | 4/1/2026 | A · Award | +75K | 7.61 | — | 75K |